<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS/HYPOTHESIS: We sought to evaluate the effects of <z:hpo ids='HP_0001513'>obesity</z:hpo> and <z:hpo ids='HP_0001513'>obesity</z:hpo>-related type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> on cardiac geometry (remodelling) and systolic and diastolic function in adolescents and young adults </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Cardiac structure and function were compared by echocardiography in participants who were lean, <z:mp ids='MP_0001261'>obese</z:mp> or <z:mp ids='MP_0001261'>obese</z:mp> with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> (<z:mp ids='MP_0001261'>obese</z:mp> diabetic), in a cross sectional study </plain></SENT>
<SENT sid="2" pm="."><plain>Group differences were assessed using ANOVA </plain></SENT>
<SENT sid="3" pm="."><plain>Independent determinants of cardiac outcome measures were evaluated with general linear models </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Adolescents with <z:hpo ids='HP_0001513'>obesity</z:hpo> and <z:hpo ids='HP_0001513'>obesity</z:hpo>-related type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> were found to have abnormal cardiac geometry compared with lean controls (16% and 20% vs &lt;1%, p &lt; 0.05) </plain></SENT>
<SENT sid="5" pm="."><plain>These two groups also had increased systolic function </plain></SENT>
<SENT sid="6" pm="."><plain>Diastolic function decreased from the lean to <z:mp ids='MP_0001261'>obese</z:mp> to <z:mp ids='MP_0001261'>obese</z:mp> diabetic groups with the lowest diastolic function observed in the <z:mp ids='MP_0001261'>obese</z:mp> diabetic group (p &lt; 0.05) </plain></SENT>
<SENT sid="7" pm="."><plain>Regression analysis showed that group, BMI z score (BMIz), group Ã— BMIz interaction and systolic BP z score (BPz) were significant determinants of cardiac structure, while group, BMIz, systolic BPz, age and fasting <z:chebi fb="105" ids="17234">glucose</z:chebi> were significant determinants of the diastolic function (<z:hpo ids='HP_0000001'>all</z:hpo> p &lt; 0.05) </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS/INTERPRETATION: Adolescents with <z:hpo ids='HP_0001513'>obesity</z:hpo> and <z:hpo ids='HP_0001513'>obesity</z:hpo>-related type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> demonstrate changes in cardiac geometry consistent with cardiac remodelling </plain></SENT>
<SENT sid="9" pm="."><plain>These two groups also demonstrate decreased diastolic function compared with lean controls, with the greatest decrease observed in those with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="10" pm="."><plain>Adults with diastolic dysfunction are known to be at increased risk of progressing to <z:hpo ids='HP_0001635'>heart failure</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>Therefore, our findings suggest that adolescents with <z:hpo ids='HP_0001513'>obesity</z:hpo>-related type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> may be at increased risk of progressing to early <z:hpo ids='HP_0001635'>heart failure</z:hpo> compared with their <z:mp ids='MP_0001261'>obese</z:mp> and lean counterparts </plain></SENT>
</text></document>